Skip Navigation

Andrew Skodyn

Andrew Skodyn
Andrew Skodyn Partner | Toronto
Select Experience

A representative list of Andrew's cases of public record includes:

  • Janssen and the Kennedy Trust in a patent impeachment and infringement action related to Remicade (infliximab), a biologic treatment for rheumatoid arthritis; first patent infringement action in Canada relating to a subsequent entry biologic, a generic version of a biologic drug, also referred to as a biosimilar (Janssen Inc v. Pfizer Canada Inc.)

  • IBM in a passing-off action relating to IBM's cloud computing services and technologies (Smart Cloud Inc v. International Business Machines Corporation)

  • Instagram in a patent infringement action relating to methods for the sharing of content on social media (United American Corp, et al. v. Instagram)

  • Auxly in a commercial dispute relating to a distribution agreement for cannabis products (Auxly Cannabis Group Inc. v. Care Group of Pharmacies Inc., et al.)

  • Bausch Health and Valeant in a class action relating to the marketing and sale of products containing opioids (The Province of British Columbia v. Apotex Inc., et al.)

  • Janssen in proceedings pursuant to the PM(NOC) Regulations relating to Prezista (darunavir), an antiretroviral medication (Janssen Inc. v. Apotex Inc.)

  • Valeant in proceedings pursuant to the PM(NOC) Regulations relating to Glumetza (metformin), a medication used to treat type 2 diabetes (Valeant Canada LP v. Generic Partners Canada Inc.)

  • Valeant in proceedings pursuant to the PM(NOC) Regulations relating to Wellbutrin XL (bupropion hydrochloride), a medication used to treat depression (Valeant Canada LP v. Ranbaxy Pharmaceuticals Canada Inc.)

  • Janssen in a patent impeachment and infringement action relating to Velcade (bortezomib), a product used to treat certain cancers (Teva Canada Limited v. Janssen Inc.)

  • Valeant in an action for damages under section 8 of the PM(NOC) Regulations relating to Sublinox (zolpidem), a medication used to treat insomnia (Pharmascience Inc. v. Valeant Canada LP)

  • IBM in a patent infringement action relating to video monitoring technologies (Hawk Technology Systems, LLC v. IBM Canada Limited)

  • The responding party on an interlocutory injunction relating to an alleged business disruption from the termination of software licence agreements (Northrop Grumman Corporation v. OpenText Corporation)

  • Venngo in an appeal to the Federal Court of Appeal of a decision relating to trademark infringement and passing off (Venngo Inc. v. Concierge Connection Inc. c.o.b. as Perkopolis)

  • The Kennedy Trust in a patent dispute, including the first unanimous five-judge decision of the Federal Court of Appeal, which changed the standard of review applicable to the decisions of Prothonotaries to be in accordance with Housen v. Nikolaisen, overturning a long line of prior authority (Hospira Healthcare Corporation v. The Kennedy Trust)

Awards & Recognition

Andrew is consistently recognized as a leading intellectual property and commercial litigator in the following publications:

  • The Best Lawyers in Canada – 2013–2023 (Corporate and Commercial Litigation, Intellectual Property Law, Biotechnology Law)

  • Chambers Canada: Canada's Leading Lawyers for Business – 2016–2023 (Intellectual Property: Litigation – Canada)

  • Thomson Reuters Stand-out Lawyer – Independently Rated Lawyers – 2019–2022 (As nominated by senior in-house counsel)

  • Chambers Global: The World's Leading Lawyers for Business – 2011–2022 (Intellectual Property: Litigation)

  • Benchmark Canada: The Definitive Guide to Canada's Leading Litigation Firms and Attorneys – 2012–2022 (Litigation Star)

  • The Canadian Legal Lexpert Directory – 2016, 2018–2022 (Intellectual Property, Litigation – Intellectual Property and Life Sciences & Health)

  • WTR 1000: The World's Leading Trademark Professionals 2022 (Recommended Individual – Enforcement and Litigation)

  • Who's Who Legal: Patents – 2017–2022

  • Who's Who Legal: Life Sciences – 2017–2022 (Patent Litigation)

  • Who's Who Legal: Canada – 2016–2022 (Life Sciences and Patents)

  • Who's Who Legal: Global – 2021–2022 (IP – Patents, Life Sciences – Patent Litigation)

  • Managing Intellectual Property IP Stars Handbook – 2016–2022 (Patent Star and Trademark Star)

  • IAM Patent 1000: The World's Leading Patent Professionals – 2012–2022 (Recommended Individual – Patent Litigation: Silver)

Professional Activities

Andrew is a regular speaker on intellectual property and advocacy issues.

He is also an active member of numerous professional organizations, including the Intellectual Property Institute of Canada (Litigation and Life Sciences Committees), the Canadian Bar Association (Court Practice, Professional Development and Patents and Industrial Designs Committees), the Intellectual Property Owners Association (Women in IP and Pharmaceutical & Biotechnology Issues Committees), The Advocates' Society and the American Bar Association (Intellectual Property Law Section). 

Andrew is also a member of the editorial board of the Canadian Intellectual Property Review.

Education

Admitted to the Ontario Bar – 1999
LLB, Queen's University – 1997
BSc, University of Calgary – 1994

More insights

Save Profile

Select sections to customize your PDF

Share Profile